Position in ABBV
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$84,235,735
+$12,370,732 QoQ
Shares Held
334,747
+1.3% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
2.59%
of 13F equity value
Holder Rank
#279
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Capital Investment Advisors, LLC holds $319,084,682 across 12 Drug Manufacturers - General names. ABBV ranks #2 (26.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
414,618 | $105,300,533 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
334,747 | $84,235,735 | |
| 3 | MRK |
Merck & Co., Inc.
|
376,564 | $48,388,474 | |
| 4 | LLY |
ELI LILLY & Co
|
29,637 | $35,547,509 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
93,913 | $11,864,968 | |
| 6 | AMGN |
Amgen Inc
|
31,607 | $11,445,526 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
194,661 | $11,216,366 | |
| 8 | PFE |
Pfizer Inc
|
398,271 | $9,590,365 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $84,235,735 | 334,747 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $71,865,003 | 330,429 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $71,531,993 | 313,064 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $70,839,663 | 305,950 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $35,596,904 | 191,773 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $39,619,184 | 189,095 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $33,854,870 | 190,517 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $37,192,198 | 188,334 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $32,237,527 | 187,952 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $33,641,882 | 184,744 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $28,462,100 | 183,662 | Shares | Sole | 2024-01-05 | |
| 2023-09-30 | $27,293,035 | 183,101 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $24,828,179 | 184,281 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $29,796,930 | 186,967 | Shares | Sole | 2023-04-10 | |
| 2022-12-31 | $29,552,974 | 182,866 | Shares | Sole | 2023-01-05 | |
| 2022-09-30 | $24,131,226 | 179,802 | Shares | Sole | 2022-10-05 | |
| 2022-06-30 | $26,404,477 | 172,398 | Shares | Sole | 2022-07-06 | |
| 2022-03-31 | $27,627,596 | 170,425 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $23,120,768 | 170,759 | Shares | Sole | 2022-01-10 | |
| 2021-09-30 | $17,892,936 | 165,875 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $17,642,577 | 156,628 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $15,971,865 | 147,587 | Shares | Sole | 2021-04-27 | |
| 2020-12-31 | $14,532,111 | 135,624 | Shares | Sole | 2021-01-21 | |
| 2020-09-30 | $11,060,076 | 126,271 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $11,744,095 | 119,618 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $8,136,025 | 106,786 | Shares | Sole | 2020-04-13 | |
| No filing history on record for this holder in this stock. | ||||||